These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11819005)

  • 1. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy.
    Parker MG; Fraser GL; Watson DM; Riker RR
    Intensive Care Med; 2002 Jan; 28(1):81-4. PubMed ID: 11819005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation.
    Barnes BJ; Gerst C; Smith JR; Terrell AR; Mullins ME
    Pharmacotherapy; 2006 Jan; 26(1):23-33. PubMed ID: 16422667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations.
    Neale BW; Mesler EL; Young M; Rebuck JA; Weise WJ
    Ann Pharmacother; 2005 Oct; 39(10):1732-6. PubMed ID: 16159998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions.
    Horinek EL; Kiser TH; Fish DN; MacLaren R
    Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity.
    Yahwak JA; Riker RR; Fraser GL; Subak-Sharpe S
    Pharmacotherapy; 2008 Aug; 28(8):984-91. PubMed ID: 18657015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam.
    Zar T; Yusufzai I; Sullivan A; Graeber C
    Nat Clin Pract Nephrol; 2007 Sep; 3(9):515-20. PubMed ID: 17717564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults.
    Arroliga AC; Shehab N; McCarthy K; Gonzales JP
    Crit Care Med; 2004 Aug; 32(8):1709-14. PubMed ID: 15286548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylene glycol accumulation during continuous-infusion lorazepam in critically ill patients.
    Wilson KC; Farber HW
    J Intensive Care Med; 2008; 23(6):413; author reply 414-5. PubMed ID: 19019841
    [No Abstract]   [Full Text] [Related]  

  • 9. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital.
    Miller MA; Forni A; Yogaratnam D
    Ann Pharmacother; 2008 Oct; 42(10):1502-6. PubMed ID: 18698010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition, treatment, and prevention of propylene glycol toxicity.
    Zar T; Graeber C; Perazella MA
    Semin Dial; 2007; 20(3):217-9. PubMed ID: 17555487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolar gap metabolic acidosis in a 60-year-old man treated for hypoxemic respiratory failure.
    Arbour R; Esparis B
    Chest; 2000 Aug; 118(2):545-6. PubMed ID: 10936154
    [No Abstract]   [Full Text] [Related]  

  • 12. Propylene glycol toxicity related to high-dose lorazepam infusion: case report and discussion.
    Arbour RB
    Am J Crit Care; 1999 Jan; 8(1):499-506. PubMed ID: 9987548
    [No Abstract]   [Full Text] [Related]  

  • 13. Propylene glycol-associated renal toxicity from lorazepam infusion.
    Yaucher NE; Fish JT; Smith HW; Wells JA
    Pharmacotherapy; 2003 Sep; 23(9):1094-9. PubMed ID: 14524641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A life-threatening double gap metabolic acidosis.
    Tsao YT; Tsai WC; Yang SP
    Am J Emerg Med; 2008 Mar; 26(3):385.e5-6. PubMed ID: 18358977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe lactic acidosis after an iatrogenic propylene glycol overdose.
    Zosel A; Egelhoff E; Heard K
    Pharmacotherapy; 2010 Feb; 30(2):219. PubMed ID: 20099997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients.
    Chicella M; Jansen P; Parthiban A; Marlowe KF; Bencsath FA; Krueger KP; Boerth R
    Crit Care Med; 2002 Dec; 30(12):2752-6. PubMed ID: 12483068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylene glycol toxicity occurs during low-dose infusions of lorazepam.
    Arbour R
    Crit Care Med; 2003 Feb; 31(2):664-5; author reply 665. PubMed ID: 12576996
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of propylene glycol toxic reaction associated with etomidate infusion.
    Bedichek E; Kirschbaum B
    Arch Intern Med; 1991 Nov; 151(11):2297-8. PubMed ID: 1953236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe propylene glycol toxicity secondary to use of anti-epileptics.
    Pillai U; Hothi JC; Bhat ZY
    Am J Ther; 2014; 21(4):e106-9. PubMed ID: 22926232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propylene glycol ingestion causes D-lactic acidosis.
    Christopher MM; Eckfeldt JH; Eaton JW
    Lab Invest; 1990 Jan; 62(1):114-8. PubMed ID: 2296157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.